Hostname: page-component-8448b6f56d-wq2xx Total loading time: 0 Render date: 2024-04-23T12:18:42.270Z Has data issue: false hasContentIssue false
  • English
  • Français

Therapeutic insemination by donor II: A review of its known risks

Published online by Cambridge University Press:  03 June 2009

Jeanne V Linden  and
John K Critser
Jeanne V Linden*
Affiliation:
Wadsworth Center for Laboratories and Research, New York State Department of Health, Albany, New York
John K Critser
Affiliation:
Cryobiology Research Institute, Methodist Hospital of Indiana, Indianapolis, Indiana, USA
*
Wadsworth Center for Laboratories and Research, New York State Department of Health, PO Box 509, Albany, NY 12201–0509, New York, USA.
Get access Rights & Permissions [Opens in a new window]

Extract

In an effort to summarize the potential risks of therapeutic insemination by donor (TID), including a review of cases of disease attributed to donor semen, a MEDLINE literature search was conducted to identify all published case reports of transmissible diseases occurring in donor semen recipients published in English between 1975 and 1992. The reference list for each article was reviewed to locate additional published case reports. Pertinent case reports were compiled according to disease agent and classified into viral, bacterial and other categories.

Type
Articles
Information
Reproductive Medicine Review , Volume 4 , Issue 1 , March 1995 , pp. 19 - 29
Copyright
Copyright © Cambridge University Press 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1Simonds, RJ, Holmberg, SD, Hurwitz, RL et al. Transmission of human immunodeficiency virus type 1 from a seropositive organ and tissue donor. N Engl J Med 1992; 326: 726–32.Google Scholar
2World Health Organization. Infections, pregnancies, and infertility: perspective on prevention. Fertil Steril 1987; 47: 964–68.CrossRefGoogle Scholar
3Horne, HW Jr. Artificial insemination, donor: an issue of ethical and moral values. N Engl J Med 1975; 293: 873–74.CrossRefGoogle ScholarPubMed
4Kemp, JE. The infectiousness of semen of patients with late syphilis, an experimental study. Am J Syph Gonor Ven Dis 1938; 22: 401–25.Google Scholar
5Sweet, RL, Landers, DW, Walker, CB, Schachter, J. Chlamydia trachomatis and pregnancy outcome. Am J Obstet Gynecol 1987; 156: 824–33.CrossRefGoogle ScholarPubMed
6Stokes, JH, Beerman, H, Ingraham, NR. Modern clinical syphilology. Philadelphia: WB Saunders, 1944.Google Scholar
7Stone, SC. Complications and pitfalls of artificial insemination. Clin Obstet Gynecol 1980; 23: 667–82.CrossRefGoogle ScholarPubMed
8Behrman, SJ. Artificial insemination and public policy, N Engl J Med 1979; 300: 619–20.Google Scholar
9Stewart, GJ, Cunningham, AL, Driscoll, GL et al. Transmission of human T-cell lymphotropic virus type III by AID. Lancet 1985; ii: 581–84.Google Scholar
10Chiasson, MA, Stonebumer, RL, Joseph, SC. Human immunodeficiency virus transmission through artificial insemination. J Acquir Immune Defic Syndr 1990; 3: 69–72.Google Scholar
11Tyler, JP, Dobler, KJ, Driscoll, GL, Stewart, GJ. The impact of AIDS on artificial insemination by donors. Clin Reprod Fertil 1986; 4: 305–17.Google Scholar
12Centers for Disease Control. HIV-1 infection and artificial insemination with processed semen. Morb Mortal Wkly Rep 1990; 39: 249: 255–56.Google Scholar
13Semprini, AE, Levi-Setti, P, Bozzo, M et al. Insemination of HIV-negative women with processed semen of HIV-positive partners. Lancet 1992; 340: 1317–19.Google Scholar
14Rekart, ML. HIV transmission by artificial insemination. Presented at the IVth International Conference on AIDS, Stockholm, Sweden, 13–16 06 1988. Washington, DC: BIO-DATA Publishers, 1993: 266 (abstract no. 4026).Google Scholar
15Mascola, L, Araneta, M, Eller, A et al. Risk of HIV infection following artificial insemination. Presented at the IXth International Conference on AIDS in affiliation with the IVth STD World Congress, Berlin, Germany, 7–11 06 1993: p 647 (abstract no. PO-CO2-2583).Google Scholar
16Zagury, D, Fouchard, M, Cheynier, R et al. Evidence for HTLV-III in T-cells from semen of AIDS patients: expression in primary cell culture, long-term mitogen-stimulated cell cultures, and cultures with a permissive T-cell line. Cancer Res 1985; 45: 4595s–97s.Google ScholarPubMed
17Berry, WR, Gottesfeld, RL, Alter, HJ et al. Transmission of hepatitis B virus by artificial insemination. JAMA 1987; 257: 1079–81.CrossRefGoogle ScholarPubMed
18Mascola, L, Guinan, ME. Semen donors as the source of sexually transmitted diseases in artificially inseminated women: the saga unfolds. JAMA 1987; 257 1093–94.CrossRefGoogle ScholarPubMed
19Scott, RM, Snitbhan, R, Bancroft, WH, Alter, HJ, Tingpalapong M. Experimental transmission of hepatitis B virus by semen and saliva. J Infect Dis 1980;142: 67–71.Google Scholar
20Wright, RA. Hepatitis B and the HBsAg carrier: an outbreak related to sexual contact. JAMA 1975; 232: 717–21.CrossRefGoogle Scholar
21Behrman, SJ. Artificial insemination. In: Behrman, SJ, Kistner, RW eds. Progress in infertility. Boston: Little Brown, 1968: 779–89.Google Scholar
22Alter, MJ, Hadler, SC, Judson, FN et al. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 1990; 264: 2231–35.CrossRefGoogle ScholarPubMed
23Fiumara, NJ. Transmission of gonorrhoea by artificial insemination. Br J Vener Dis 1972; 48: 308–309.Google Scholar
24Strickler, RC, Keller, DW, Women, JC. Artificial insemination with fresh donor semen. N Engl J Med 1975; 293: 848–53.CrossRefGoogle ScholarPubMed
25Hansen, KB, Nielsen, NC, Rebbe, H. Artificial insemination in Denmark by frozen donor semen supplied from a central bank. Br J Obstet Gynaecol 1979; 86: 384–86.CrossRefGoogle ScholarPubMed
26Sherman, JK, Rosenfeld, J. Importance of frozenstored human semen in the spread of gonorrhea. Fertil Steril 1975; 26: 1043–47.CrossRefGoogle ScholarPubMed
27Jenning, RT, Dixon, RE, Nettles, JB. The risks and prevention of Neisseria gonorrhoeae transfer in fresh ejaculate donor insemination. Fertil Steril 1977; 28: 554–56.Google Scholar
28Garcia, A, Sierra, MF, Friberg, J. Survival of bacteria after freezing of human semen in liquid nitrogen. Fertil steril 1981; 35: 549–51.Google Scholar
29Glander, HJ, Rytter, M, Baumann, L, Schönborn, C. Risk of transmission of sexually transmitted diseases by cryopreserved semen. Andrologia 1986; 18: 323–25.CrossRefGoogle ScholarPubMed
30Barwin, BN. Transmission of Ureaplasma urealyticum by artificial insemination. Fertil Steril 1984; 41: 326–27.Google Scholar
31Caspi, E, Herczeg, E, Solomon, F, Sompolinsky, D. Amnionitis and T strain mycoplasmemia. Am J Obstet Gynecol 1971; 111: 1102–1106.Google Scholar
32Kleegman, SJ. Therapeutic donor insemination. Conn Med 1967; 31: 705–13.Google ScholarPubMed
33Moore, DE, Ashley, RL, Zarutskie, PW et al. Transmission of genital herpes by donor insemination. JAMA 1989; 261: 3441–43.CrossRefGoogle ScholarPubMed
34Sherman, JK, Menna, JH. Cryosurvival of herpes simplex virus-2 during cryopreservation of human spermatozoa. Cryobiology 1986; 23: 383–85.Google Scholar
35Nagel, TC, Tagatz, GE, Campbell, BF. Transmission of Chlamydia trachomatis by artificial insemination. Fertil Steril 1986; 46: 959–60.Google Scholar
36Berger, RE, Alexander, ER, Monda, GD, Ansell, J, McCormick, G, Holmes, K. Chlamydia trachomatis as a cause of acute ‘idiopathic’ epididymitis. N Engl J Med 1978; 298: 301–304.CrossRefGoogle ScholarPubMed
37Sherman, JK, Jordan, GW. Cryosurvival of Chlamydia trachomatis during cryopreservation of human spermatozoa. Fertil Steril 1985; 43: 664–66.Google Scholar
38Haman, JO. Therapeutic donor insemination: a review of 440 cases. Calif Med 1959; 90: 130–33.Google Scholar
39Chong, AP, Taymor, ML. Sixteen years' experience with therapeutic donor insemination. Fertil Steril 1975; 26: 791–95.CrossRefGoogle ScholarPubMed
40Hammitt, DG, Aschenbrenner, DW, Williamson, RA. Culture of cytomegalovirus from frozen thawed semen. Fertil Steril 1988; 49: 554–57.Google Scholar
41Elmer-DeWitt, P. The crudest kind of fraud. Time 1991 12 2; 138 (22): 27.Google Scholar
42The Wall Street Journal 1992 03 5; CCXIX (45): 1.Google Scholar
43 Fertility doctor gets five years. The New York Times 1992 9 05; CXLI(48,961): 8L.Google Scholar
44Office of Technology Assessment, Congress of the United States. Artificial insemination: practice in the United States. Washington: US Government Printing Office, 1988.Google Scholar
45Sherman, JK. History of artificial insemination and the development of human semen banking. In: LaSalle, B, Rinfret, AP eds. The integrity of frozen spermatozoa. Washington, DC: National Academy of Sciences, 1978: 201–207.Google Scholar
46Barratt, CLR, Chauhan, M, Cooke, ID. Donor insemination – a look to the future. Fertil Steril 1990; 54: 374–87.Google ScholarPubMed
47Martin, RH, Chernos, JE, Radmaker, AW. Effect of cryo-preservation on the frequency of chromosomal abnormalities and sex ratio in human sperm. Mol Reprod Dev 1991; 30: 159–62.Google Scholar
48Sonenthal, KR, McKnight, T, Shaughnessy, MS, Grammer, LC, Jeyendran, RS. Anaphylaxis during intrauterine insemination secondary to bovine serum albumin. Fertil Steril 1991; 56: 1188–91.CrossRefGoogle ScholarPubMed
49Smith, YR, Hurd, WW, Menge, AC, Sanders, GM, Ansbacher, R, Randolph, JF. Allergic reactions to penicillin during in vitro fertilization and intrauterine insemination. Fertil Steril 1992; 58: 847–49.CrossRefGoogle ScholarPubMed
50Johnson, LA, Welch, GR, Keyvanfar, K, Dorfmann, A, Fugger, EF, Schulman, JD. Gender preselection in humans? Flow cytometric separation of X and Y spermatozoa for the prevention of X-linked diseases. Hum Reprod 1993; 8: 1733–39.Google Scholar
51Schroeder-Jenkins, M, Rothman, SA. Causes of donor rejection in a sperm banking program. Fertil steril 1989; 51: 903–906.Google Scholar
52Chauhan, M, Barratt, CLR, Cooke, S, Cooke, ID. A protocol for the recruitment and screening of semen donors for an artificial insemination by donor programme. Hum Reprod 1988; 3: 873–76.CrossRefGoogle ScholarPubMed
53Bordson, BL, Ricci, E, Dickey, RP, Dunaway, H, Taylor, SN, Curole, DN. Comparison of fecundability with fresh and frozen semen in therapeutic donor insemination. Fertil Steril 1986; 46: 466–69.Google Scholar
54Keel, BA, Webster, BW. Semen analysis data from fresh and cryopreserved donor ejaculates: comparison of cryoprotectants and pregnancy rates. Fertil steril 1989; 52: 100–105.Google Scholar
55American Association of Tissue Banks. Standards for tissue banking. McLean, Virginia: AATB, 1993.Google Scholar
56American Fertility Society. New guidelines for the use of semen donor insemination: 1986. Fertil Steril 1986; 46(suppl 2): 95S–103S.Google Scholar
57American Fertility Society. Revised new guidelines for the use of semen-donor insemination: 1988. Fertil Sferil 1988; 49: 211.Google Scholar
58American Fertil Society. New guidelines for the use of semen donor insemination: 1990. Fertil Steril 1990; 53: (suppl 1): 1S–13S.Google Scholar
59Centers for Disease Control. Testing donors of organs, tissues, and semen for antibody to human T-lymphotropic type Ill/lymphadenopathy-associated virus. Morb Mortal Wkly Rep 1985; 34: 294.Google Scholar
60Centers for Disease Control. Semen banking, organ and tissue transplantation, and HIV antibody testing. Morb Mortal Wkly Rep 1988; 37: 57–58, 63.Google Scholar
61Centers for Disease Control. Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs. Morb Mortal Wkly Rep 1994; 43: 13–14.Google Scholar